HSP90AA1 and cancer: Therefore, as an example of relevant pro-apoptotic pathways, the inhibition of Hsp90 blocks the activation of nuclear factor kappa B (NF-κB), and inhibits the VEGFR2 pathway, all leading to apoptotic events of the cancer cell machinery [10,11].